triiodothyronine has been researched along with oxytetracycline, anhydrous in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Huang, L; Li, X; Qiu, Y; Wang, W; Yi, X; Yu, K; Yu, X; Zeng, X | 1 |
Cai, K; Huang, L; Li, H; Qiu, Y; Wang, W; Xu, S; Yi, X; Yu, K; Yu, X | 1 |
1 review(s) available for triiodothyronine and oxytetracycline, anhydrous
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for triiodothyronine and oxytetracycline, anhydrous
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Low-dose effects on thyroid disruption in zebrafish by long-term exposure to oxytetracycline.
Topics: Animals; Endocrine Disruptors; Oxytetracycline; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine; Water Pollutants, Chemical; Zebrafish | 2020 |
Long-term low-dose oxytetracycline potentially leads to neurobehavioural changes.
Topics: Animals; Anti-Bacterial Agents; Molecular Docking Simulation; Oxytetracycline; Triiodothyronine; Zebrafish | 2021 |